Compound: bekanamycin
SMILES: O1[C@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@@H]([C@@H](O)[C@@H]([C@H]3N)O)CN)[C@@H](N)C[C@H]2N)[C@H](O)[C@@H](N)[C@@H]([C@H]1CO)O
InChIKey: SKKLOUVUUNMCJE-FQSMHNGLSA-N
Synonyms: bekanamycin, Kanamycin B, 4696-76-8, Nebramycin V, Bekanamycine, nebramycin factor 5, Bekanamycinum, NK 1006, 2'-Amino-2'-deoxykanamycin, Bekanamicina, NK-1006, 15JT14C3GI, DTXSID8023185, DTXCID903185, CHEBI:28098, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol, (1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2S,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxyoxane-3,4-diol, RefChem:561213, J01GB13, 225-170-5, Aminodeoxykanamycin, Bekanamycin [INN], MFCD01683541, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol, Bekanamycin (INN), (1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside, Becanamicina, Antibiotic derived from Streptomyces kanamyceticus. Kanamycin B, C18H37N5O10, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1->6))-2-deoxy-D-streptamine, Bekanamycine [INN-French], Bekanamycinum [INN-Latin], Becanamicina [INN-Spanish], UNII-15JT14C3GI, kananmycin B, NCGC00096063-01, 9CS, EINECS 225-170-5, BRN 0061646, Spectrum_001112, Kanamycin B; Bekanamycin, Spectrum2_000640, Spectrum3_000619, Spectrum4_001831, Spectrum5_000621, KANAMYCIN B [MI], CHEMBL176, BEKANAMYCIN [WHO-DD], BSPBio_002158, KBioGR_002528, KBioSS_001592, SCHEMBL158426, SPBio_000640, MEGxm0_000486, orb1299205, ACon0_001346, GTPL12182, KBio2_001592, KBio2_004160, KBio2_006728, KBio3_001658, SKKLOUVUUNMCJE-FQSMHNGLSA-N, HY-B1174, Tox21_113194, BDBM50368267, EBC-98151, AKOS030526149, AK31430, CS-4772, DB13673, Kanamycin B; Tobramycin EP Impurity A, SDCCGMLS-0066707.P001, NCGC00178790-01, SY365104, CAS-4696-76-8, SBI-0052603.P002, TOBRAMYCIN IMPURITY A [EP IMPURITY], NS00011539, C00825, D07497, AB00053732_02, Antibiotic derived from Streptomyces kanamyceticus, F787610, Q3637540, BRD-K73425385-001-01-9, BRD-K73425385-065-04-8, (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSIDE, .ALPHA.-D-GLUCOPYRANOSIDE, (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-6))-2-deoxy-
Theoretical properties:
molecular_formula: C18H37N5O10
molecular_weight: 483.5 g/mol
exact_mass: 483.25404239 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 11
hydrogen_bond_acceptor_count: 15
rotatable_bond_count: 6
heavy_atom_count: 33
topological_polar_surface_area: 288 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Kanamycin B is a member of kanamycins. It is a conjugate base of a kanamycin B(5+).
chembl: BEKANAMYCIN is a small molecule listed in the ChEMBL database and has reached clinical trial phase 3.0.
wikipedia: Bekanamycin (INN; kanamycin B) is an aminoglycoside antibiotic.